Meet intelligent genomics
Quantgene started in 2015 at UC Berkeley.
8 years later, and $36m invested in R&D,
We're launching Qx™ and Qi™ genomics platforms, available across the US.1
By combining genomics algorithms with patented high sensitivity diagnostics technology, imaging, and medical data, we offer comprehensive medical intelligence that helps identify early signals of cancer helping patients achieve preventative and targeted clinical outcomes.
1 Except New York.
Our clinical research partners